Skip to content
  • Thursday, 21 May 2026
  • 11:04 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Wegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key Markets
Pharmaceutical R&D

Wegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key Markets

Teuku Ryan Mar 20, 2026 0

The U.S. Food and Drug Administration (FDA) has granted approval for a higher-dose formulation of Novo Nordisk’s blockbuster weight-loss medication,…

Read More
Closing the Information Gap: ETH Zürich Team Integrates Function and Binding in One Drug Screening AssayScience News: A Centennial of Empowering Public Understanding of ScienceScience News: Empowering Public Understanding of Science Since 1921Fish oil may be hurting your brain, new study finds
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Biotech Bi-Weekly Delivers Insight into Breakthrough Product Launches, Strategic Alliances, and Financial Shifts Shaping the IndustryPharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report RevealsAnalyzing Natural Speech Patterns Provides Crucial Indicators of Brain Health and Executive Function Across the LifespanTakeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
YOU MAY HAVE MISSED
Biotech & Genetic Research
Biotech Bi-Weekly Delivers Insight into Breakthrough Product Launches, Strategic Alliances, and Financial Shifts Shaping the Industry
Jia Lissa May 21, 2026
Laboratory Automation & Robotics
Pharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report Reveals
Lana Keisha May 21, 2026
Neuroscience & Brain Research
Analyzing Natural Speech Patterns Provides Crucial Indicators of Brain Health and Executive Function Across the Lifespan
Rifan Muazin May 21, 2026
Pharmaceutical R&D
Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
Teuku Ryan May 21, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ